These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21042277)

  • 1. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
    Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular signal-regulated kinase 1 interacts with and phosphorylates CdGAP at an important regulatory site.
    Tcherkezian J; Danek EI; Jenna S; Triki I; Lamarche-Vane N
    Mol Cell Biol; 2005 Aug; 25(15):6314-29. PubMed ID: 16024771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stretch of polybasic residues mediates Cdc42 GTPase-activating protein (CdGAP) binding to phosphatidylinositol 3,4,5-trisphosphate and regulates its GAP activity.
    Karimzadeh F; Primeau M; Mountassif D; Rouiller I; Lamarche-Vane N
    J Biol Chem; 2012 Jun; 287(23):19610-21. PubMed ID: 22518840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
    Khoury H; Dankort DL; Sadekova S; Naujokas MA; Muller WJ; Park M
    Oncogene; 2001 Feb; 20(7):788-99. PubMed ID: 11314013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
    Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing contributions of LIMK and ROCK to TGFβ-induced transcription, motility and invasion.
    Morin P; Wickman G; Munro J; Inman GJ; Olson MF
    Eur J Cell Biol; 2011 Jan; 90(1):13-25. PubMed ID: 21074289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
    I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
    J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
    Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
    Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
    Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
    Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
    J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
    Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility.
    Brandt B; Kemming D; Packeisen J; Simon R; Helms M; Feldmann U; Matuschek A; Kersting C; Hinrichs B; Bidart JM; Bellet D; Bartkowiak K; Dankbar N; Dittmar T; Sauter G; Boecker W; Buerger H
    Endocr Relat Cancer; 2005 Dec; 12(4):823-37. PubMed ID: 16322324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
    Seton-Rogers SE; Lu Y; Hines LM; Koundinya M; LaBaer J; Muthuswamy SK; Brugge JS
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1257-62. PubMed ID: 14739340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.